Clincosm LogoSign in Get a demo

Sickle Cell Disease

Showing NaN - NaN of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in Worldwide (voxelotor, Placebo)

Completed
Has Results
  • Sickle Cell Disease
  • Birmingham, Alabama
  • +61 more
Jan 5, 2021

Sickle Cell Disease Trial in New York (Placebo, Mometasone)

Recruiting
  • Sickle Cell Disease
  • New York, New York
  • +1 more
Nov 24, 2020

Sickle Cell Disease, Vitamin D Deficiency, Acute Chest Syndrome Trial in New York (Experimental: Vitamin D3 100,000 IU, Active

Completed
  • Sickle Cell Disease
  • +4 more
  • Experimental: Vitamin D3 100,000 IU
  • Active Comparator: Vitamin D3 12,000 IU
  • New York, New York
    Columbia University Medical Center
Jul 23, 2020

Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

Active, not recruiting
  • Bone Marrow Failure Syndrome
  • +15 more
  • CD34 Stem Cell Selection Therapy
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
Jun 17, 2020

Sickle Cell Disease Trial in New York (Vitamin D3)

Completed
  • Sickle Cell Disease
  • Vitamin D3
  • New York, New York
    Columbia University Medical Center
Sep 29, 2019

Sickle Cell Disease Trial in New York (Mometasone Furoate, Placebo)

Completed
Has Results
  • Sickle Cell Disease
  • Mometasone Furoate
  • Placebo
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 8, 2019

Vitamin D3 in Patients With Sickle Cell Disease

Completed
  • Sickle Cell Disease
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jan 17, 2018

    Sickle Cell Disease Trial in Bronx, New York (Community Health Worker (CHW), Education)

    Completed
    • Sickle Cell Disease
    • Community Health Worker (CHW)
    • Education
    • Bronx, New York
    • +1 more
    Nov 29, 2017

    Sickle Cell Disease Trial in New York, Cincinnati (Hydromorphone (Standardized, weight-based dosing), Morphine Sulfate

    Completed
    Has Results
    • Sickle Cell Disease
    • Hydromorphone (Standardized, weight-based dosing)
    • +3 more
    • New York, New York
    • +1 more
    Jul 31, 2017

    Sickle Cell Disease, Thalassemia Trial in New York (Transfusion, Blood, Chelation therapy)

    Terminated
    Has Results
    • Sickle Cell Disease
    • Thalassemia
    • Transfusion
    • +2 more
    • New York, New York
      Columbia University Medical Center
    Aug 11, 2016

    High-Tc Susceptometer to Monitor Transfusional Iron Overload

    Completed
    • Transfusional Iron Overload
    • +4 more
    • Hepatic biomagnetic susceptibility measurement
    • New York, New York
      Columbia University Medical Center
    Sep 20, 2016

    Study of Blood Platelets in Sickle Cell Disease

    Withdrawn
    • Sickle Cell Disease
      • New York, New York
        Rockefeller University Hospital
      Jun 5, 2015

      Sickle Cell Disease Trial in New York (Femoral Nerve Block)

      Terminated
      Has Results
      • Sickle Cell Disease
      • Femoral Nerve Block
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Apr 6, 2015

      Sickle Cell Disease, Sickle Cell Anemia Trial in United States (Low Dose ICA-17043, High dose ICA-17043, Placebo)

      Completed
      • Sickle Cell Disease
      • Sickle Cell Anemia
      • Low Dose ICA-17043
      • +2 more
      • Birmingham, Alabama
      • +18 more
      Jul 13, 2011

      Sickle Cell Disease Trial in Worldwide (ICL670)

      Completed
      Has Results
      • Sickle Cell Disease
      • Mobile, Alabama
      • +38 more
      May 3, 2011

      Sickle Cell Disease, Iron Overload, Hemolytic Anemia Trial in Canada, United States (Deferasirox (ICL670), Deferoxamine (DFO))

      Completed
      Has Results
      • Sickle Cell Disease
      • +2 more
      • Deferasirox (ICL670)
      • Deferoxamine (DFO)
      • Birmingham, Alabama
      • +58 more
      May 23, 2011